Organogenesis Holdings (ORGO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to 0.5.
- Organogenesis Holdings' Equity Ratio fell 1982.12% to 0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5, marking a year-over-year decrease of 1982.12%. This contributed to the annual value of 0.53 for FY2024, which is 1283.18% down from last year.
- Organogenesis Holdings' Equity Ratio amounted to 0.5 in Q3 2025, which was down 1982.12% from 0.51 recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' Equity Ratio registered a high of 0.62 during Q3 2024, and its lowest value of 0.49 during Q1 2021.
- In the last 5 years, Organogenesis Holdings' Equity Ratio had a median value of 0.56 in 2022 and averaged 0.56.
- In the last 5 years, Organogenesis Holdings' Equity Ratio surged by 20472.05% in 2021 and then plummeted by 1982.12% in 2025.
- Quarter analysis of 5 years shows Organogenesis Holdings' Equity Ratio stood at 0.54 in 2021, then rose by 8.59% to 0.59 in 2022, then increased by 2.46% to 0.61 in 2023, then decreased by 12.83% to 0.53 in 2024, then fell by 5.23% to 0.5 in 2025.
- Its Equity Ratio stands at 0.5 for Q3 2025, versus 0.51 for Q2 2025 and 0.52 for Q1 2025.